Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Histopathology|November 27, 2023
FGFR1/2/3-rearranged carcinoma of the head and neck: expanded histological spectrum crossing path with high-risk HPV in the sinonasal tractYing-Hsia Chu, Kerry Mullaney, Sara E DiNapoli, et al.The American Journal of Surgical Pathology|February 22, 2019
Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal SarcomasPaolo Cotzia, Ryma Benayed, Kerry Mullaney, et al.Virchows Archiv : an International Journal of Pathology|May 30, 2025
Expanding the histologic spectrum of thyroid neoplasms with NTRK1/2/3 or ALK translocation: a single-center retrospective study of 82 casesRonald Ghossein, Ryan Instrum, Snjezana Dogan, et al.The Journal of Molecular Diagnostics : JMD|April 24, 2017
Identification of NTRK3 Fusions in Childhood Melanocytic NeoplasmsLu Wang, Klaus J Busam, Ryma Benayed, et al.Histopathology|June 19, 2024
Detection of GRM1 gene rearrangements in chondromyxoid fibroma: a comparison of fluorescence in-situ hybridisation, RNA sequencing and immunohistochemical analysisDianne Torrence, Josephine K Dermawan, Yanming Zhang, et al.The American Journal of Pathology|June 7, 2008
Down syndrome fibroblast model of Alzheimer-related endosome pathology: accelerated endocytosis promotes late endocytic defectsAnne M Cataldo, Paul M Mathews, Anne Boyer Boiteau, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 20, 2024
Expanding the Spectrum of NR4A3 Fusion-Positive Gynecologic LeiomyosarcomasAmir Momeni-Boroujeni, Kerry Mullaney, Sara E DiNapoli, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 22, 2018
Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendotheliomaGuo Zhu, Ryma Benayed, Caleb Ho, et al.The Journal of Molecular Diagnostics : JMD|April 17, 2022
Clinical Utility and Performance of an Ultrarapid Multiplex RNA-Based Assay for Detection of ALK, ROS1, RET, and NTRK1/2/3 Rearrangements and MET Exon 14 Skipping AlterationsYing-Hsia Chu, Jada Barbee, Soo-Ryum Yang, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 1, 2021
Androgen receptor splice variant-7 in breast cancer: clinical and pathologic correlationsDonna C Ferguson, Douglas A Mata, Timothy Ky Tay, et al.Pageof 2